Benzinga

Benzinga

Comments

Esperion Therapeutics Inc Activité de délit d'initié

ESPRNASDAQ
Commerce avec le public
Commerce avec le public
$3.43
0.030.88%
À la clôture: Feb 13, 4:00 PM EST
$3.44
0.010.29%
Après les heures: Feb 13, 7:54 PM EST
AperçuActualitésGainsOptionsOrientationÉvaluations des analystesTransactions internesIntérêt courtRapport sur les stocks

Activité de trading des initiés

Suivez les dernières activités de délit d'initié Esperion Therapeutics. Restez informé des achats, des ventes et de l'impact sur le marché des actions Esperion Therapeutics.

Qu’est-ce que l’activité d’initié ?

L'activité de délit d'initié implique des initiés de l'entreprise, tels que des dirigeants, des administrateurs et des employés, qui s'engagent dans des transactions sur les actions de leur propre entreprise. Les transactions d'achat et de vente des initiés fournissent des informations précieuses sur leur confiance dans les performances futures de l'entreprise.

Que font les Esperion Therapeutics Inc Insiders ?

À Esperion Therapeutics Inc, une activité interne récente a attiré l'attention. Au cours des 30 derniers jours, les initiés ont déclaré avoir vendu un total de 1.69K actions d'une valeur de $4.87K. ne signalez aucun achat au cours des 30 derniers jours.

Achats et ventes récents notables d’initiés

  • Le janvier 21, 2026 Benjamin Looker, le GENERAL COUNSEL sold 1.69K actions pour 2.88 chacune.
  • Le décembre 18, 2025 Benjamin Looker, le GENERAL COUNSEL sold 6.52K actions pour 3.67 chacune.
  • Le décembre 18, 2025 Benjamin Halladay, le CHIEF FINANCIAL OFFICER sold 7.34K actions pour 3.67 chacune.

Statistiques de propriété pour Esperion Therapeutics Inc

Actions en circulation
237.069M
Actions flottantes
236186655.0%
Actions détenues par les initiés
4.814M
Pourcentage d'actions détenu par les initiés
2.01%
Actions détenues par les institutions
72.421M
Pourcentage d'actions détenu par les institutions
30.3%
Jan 21, 2026Benjamin LookerGENERAL COUNSEL-1.69K$2.88-$4.87KSELL-0.44%384.22KJan 20View
Dec 18, 2025Sheldon L KoenigPRESIDENT AND CEO-48.24K$3.67-$177.20KSELL-3.18%1.47MDec 17View
Dec 18, 2025Benjamin HalladayCHIEF FINANCIAL OFFICER-7.34K$3.67-$26.90KSELL-1.55%467.52KDec 17View
Dec 18, 2025Benjamin LookerGENERAL COUNSEL-6.52K$3.67-$23.90KSELL-1.66%385.90KDec 17View
Oct 20, 2025Benjamin LookerGENERAL COUNSEL-1.25K$2.62-$3.28KSELL-0.32%392.42KOct 17View
Sep 18, 2025Benjamin LookerGENERAL COUNSEL-6.27K$2.80-$17.57KSELL-1.57%393.67KSep 17View
Sep 18, 2025Sheldon L KoenigPRESIDENT AND CEO-28.43K$2.79-$79.25KSELL-1.84%1.52MSep 17View
Sep 18, 2025Benjamin HalladayCHIEF FINANCIAL OFFICER-7.05K$2.81-$19.79KSELL-1.46%474.86KSep 17View
Jul 18, 2025Benjamin LookerGENERAL COUNSEL-1.30K$1.13-$1.47KSELL-0.32%399.94KJul 17View
Jul 18, 2025Benjamin HalladayCHIEF FINANCIAL OFFICER-11.00$1.11-$12.27SELL-0.00%474.46KJul 17View
Jun 18, 2025Benjamin LookerGENERAL COUNSEL-6.42K$1.15-$7.40KSELL-1.58%401.24KJun 17View
Jun 18, 2025Sheldon L KoenigPRESIDENT AND CEO-30.47K$1.11-$33.80KSELL-1.94%1.54MJun 17View
Jun 18, 2025Benjamin HalladayCHIEF FINANCIAL OFFICER-7.23K$1.15-$8.33KSELL-1.50%474.47KJun 17View
Apr 21, 2025Eric WarrenCHIEF COMMERCIAL OFFICER-108.00$0.98-$105.62SELL-0.03%370.22KApr 17View
Apr 21, 2025Benjamin HalladayCHIEF FINANCIAL OFFICER-8.00$0.96-$7.71SELL-0.00%481.70KApr 17View
Mar 19, 2025Benjamin HalladayCHIEF FINANCIAL OFFICER-3.54K$1.48-$5.24KSELL-0.73%481.71KMar 18View
Mar 19, 2025Eric WarrenCHIEF COMMERCIAL OFFICER-2.43K$1.49-$3.62KSELL-0.65%370.33KMar 18View
Mar 19, 2025Sheldon L KoenigPRESIDENT AND CEO-13.05K$1.50-$19.62KSELL-0.82%1.57MMar 18View
Feb 20, 2025Eric WarrenCHIEF COMMERCIAL OFFICER-239.00$1.87-$446.45SELL-0.15%159.76KFeb 19View
Feb 20, 2025Benjamin HalladayCHIEF FINANCIAL OFFICER-11.00$1.86-$20.46SELL-0.00%240.67KFeb 19View
Jan 21, 2025Benjamin HalladayCHIEF FINANCIAL OFFICER-9.00$2.27-$20.39SELL-0.00%240.68KJan 17View
Jan 21, 2025Eric WarrenCHIEF COMMERCIAL OFFICER-123.00$2.26-$277.98SELL-0.08%160.00KJan 17View
Dec 18, 2024Benjamin HalladayCHIEF FINANCIAL OFFICER-3.25K$2.42-$7.87KSELL-1.33%240.69KDec 17View
Dec 18, 2024Eric WarrenCHIEF COMMERCIAL OFFICER-2.23K$2.43-$5.43KSELL-1.38%160.12KDec 17View
Dec 18, 2024Sheldon L KoenigPRESIDENT AND CEO-12.45K$2.47-$30.69KSELL-1.65%739.82KDec 17View
Nov 20, 2024Eric WarrenCHIEF COMMERCIAL OFFICER-197.00$2.17-$426.50SELL-0.12%162.35KNov 19View
Oct 18, 2024Eric WarrenCHIEF COMMERCIAL OFFICER-107.00$2.12-$226.73SELL-0.07%162.55KOct 17View
Sep 18, 2024Sheldon L KoenigPRESIDENT AND CEO-14.55K$1.80-$26.13KSELL-1.90%752.27KSep 17View
Sep 18, 2024Eric WarrenCHIEF COMMERCIAL OFFICER-2.61K$1.78-$4.65KSELL-1.58%162.66KSep 17View
Aug 20, 2024Eric WarrenCHIEF COMMERCIAL OFFICER-211.00$1.95-$410.61SELL-0.13%165.27KAug 19View
Jul 19, 2024Eric WarrenCHIEF COMMERCIAL OFFICER-108.00$2.59-$279.40SELL-0.07%165.48KJul 17View
Jul 19, 2024Joanne FoodyCHIEF MEDICAL OFFICER-917.00$2.60-$2.38KSELL-0.33%272.86KJul 17View
Jun 20, 2024Joanne FoodyCHIEF MEDICAL OFFICER-3.29K$2.87-$9.42KSELL-1.19%273.78KJun 18View
Jun 20, 2024Eric WarrenCHIEF COMMERCIAL OFFICER-2.54K$2.86-$7.25KSELL-1.51%165.59KJun 18View
May 20, 2024Eric WarrenCHIEF COMMERCIAL OFFICER-192.00$2.48-$476.74SELL-0.11%168.13KMay 17View
Sep 21, 2023Eric WarrenCHIEF COMMERCIAL OFFICER-742.00$1.25-$923.79SELL-1.07%68.32KSep 20View
Aug 21, 2023Eric WarrenCHIEF COMMERCIAL OFFICER-243.00$1.41-$343.60SELL-0.35%69.06KAug 18View
Jul 20, 2023Eric WarrenCHIEF COMMERCIAL OFFICER-106.00$1.58-$168.01SELL-0.15%69.30KJul 19View
Jun 22, 2023Eric WarrenCHIEF COMMERCIAL OFFICER-603.00$1.48-$894.25SELL-0.86%69.41KJun 21View
May 18, 2023Eric WarrenCHIEF COMMERCIAL OFFICER-219.00$1.62-$355.66SELL-0.31%70.01KMay 17View
May 11, 2023MARTIN CARROLLDIRECTOR31.50K$1.55$48.83KBUY630.00%36.50KMay 10 - May 11View
May 11, 2023STEPHEN ROCAMBOLIDIRECTOR8.11K$1.50$12.13KBUY∞8.11KMay 10View
May 10, 2023Sheldon L KoenigPRESIDENT AND CEO20.00K$1.26$25.19KBUY6.83%312.82KMay 09View
Apr 20, 2023Eric WarrenCHIEF COMMERCIAL OFFICER-115.00$1.28-$146.97SELL-0.16%70.23KApr 19View
Apr 20, 2023Benjamin LookerGENERAL COUNSEL-1.29K$1.27-$1.64KSELL-1.52%83.66KApr 19View
Apr 20, 2023Joanne FoodyCHIEF MEDICAL OFFICER-938.00$1.27-$1.19KSELL-0.73%127.06KApr 19View
Mar 20, 2023Joanne FoodyCHIEF MEDICAL OFFICER-3.81K$1.78-$6.79KSELL-2.89%128.00KMar 17View
Mar 20, 2023Sheldon L KoenigPRESIDENT AND CEO-7.00K$1.78-$12.48KSELL-2.33%292.82KMar 17View
Mar 20, 2023Eric WarrenCHIEF COMMERCIAL OFFICER-526.00$1.78-$937.49SELL-0.74%70.35KMar 17View
Mar 08, 2023Eric WarrenCHIEF COMMERCIAL OFFICER-5.09K$5.05-$25.73KSELL-9.49%48.57KMar 07View
Mar 08, 2023Sheldon L KoenigPRESIDENT AND CEO-5.44K$5.06-$27.51KSELL-2.72%194.81KMar 07View
Mar 08, 2023Joanne FoodyCHIEF MEDICAL OFFICER-3.88K$5.07-$19.67KSELL-3.63%103.06KMar 07View
Jan 19, 2023Benjamin LookerGENERAL COUNSEL-6.35K$7.00-$44.40KSELL-8.96%64.45KJan 18View
Jan 19, 2023Joanne FoodyCHIEF MEDICAL OFFICER-1.19K$6.99-$8.32KSELL-1.10%106.94KJan 18View
Oct 19, 2022Joanne FoodyCHIEF MEDICAL OFFICER-942.00$7.69-$7.24KSELL-0.86%108.14KOct 18View
Oct 19, 2022Eric WarrenCHIEF COMMERCIAL OFFICER-107.00$7.69-$822.83SELL-0.20%53.66KOct 18View
Sep 20, 2022Eric WarrenCHIEF COMMERCIAL OFFICER-255.00$6.92-$1.76KSELL-0.47%53.77KSep 19View
Sep 20, 2022Sheldon L KoenigPRESIDENT AND CEO-3.39K$6.94-$23.55KSELL-1.68%198.26KSep 19View
Aug 31, 2022Eric WarrenCHIEF COMMERCIAL OFFICER1.00K$7.46$7.46KBUY1.89%54.02KAug 31View
Aug 18, 2022Eric WarrenCHIEF COMMERCIAL OFFICER-199.00$6.82-$1.36KSELL-0.37%53.02KAug 17View
Aug 08, 2022Sheldon L KoenigPRESIDENT AND CEO8.61K$5.80$49.95KBUY4.53%198.77KAug 05View
Jul 20, 2022Joanne FoodyCHIEF MEDICAL OFFICER-3.90K$6.55-$25.55KSELL-3.45%109.08KJul 19View
Jul 20, 2022Eric WarrenCHIEF COMMERCIAL OFFICER-431.00$6.58-$2.84KSELL-0.80%53.22KJul 19View
Jun 21, 2022Sheldon L KoenigPRESIDENT AND CEO-4.55K$4.99-$22.72KSELL-2.34%190.16KJun 17View
Jun 21, 2022Eric WarrenCHIEF COMMERCIAL OFFICER-256.00$4.90-$1.25KSELL-0.47%53.65KJun 17View
Jun 03, 2022MARTIN CARROLLDIRECTOR5.00K$5.64$28.18KBUY∞5.00KJun 02View
May 18, 2022Eric WarrenCHIEF COMMERCIAL OFFICER-196.00$5.98-$1.17KSELL-0.36%53.91KMay 17View
Mar 18, 2022Sheldon KoenigPRESIDENT AND CEO-571.00$4.58-$2.62KSELL-0.29%194.72KMar 17View
May 26, 2021TARGET BIOTECH VAG BIOTECH BB10% OWNER100.00K$20.22$2.02MBUY2.28%4.48MMay 24View
May 21, 2021TARGET BIOTECH VAG BIOTECH BB10% OWNER200.00K$20.37$4.07MBUY4.79%4.38MMay 19View
May 07, 2021TARGET BIOTECH VAG BIOTECH BB10% OWNER230.00K$20.21$4.65MBUY5.83%4.18MMay 05 - May 06View
Nov 04, 2020TARGET BIOTECH VAG BIOTECH BB—200.00K$25.31$5.06MPURCHASE5.34%3.95MNov 03View
Mar 12, 2020TIMOTHY MAYLEBEN—2.50K$43.00$107.50KPURCHASE2.28%112.00KMar 11View
Mar 02, 2020TIMOTHY MAYLEBEN—5.00K$49.00$245.00KPURCHASE4.78%109.50KFeb 28View
Jan 27, 2020TARGET BIOTECH VAG BIOTECH BB—20.00K$52.12$1.04MPURCHASE0.54%3.75MJan 23View
Nov 08, 2019TIMOTHY MAYLEBENPRESIDENT & CEO5.00K$36.98$184.90KBUY6.36%83.66KNov 06View
Nov 08, 2019BB Biotech AG Ivo BetschartBB Biotech AG10% OWNER75.00K$37.30$2.80MBUY2.05%3.73MNov 06View
Sep 06, 2019TIMOTHY MAYLEBENPRESIDENT & CEO7.50K$34.55$259.11KBUY10.54%78.66KSep 04 - Sep 06View
Sep 06, 2019BB Biotech AG Ivo BetschartBB Biotech AG10% OWNER80.00K$33.78$2.70MBUY2.24%3.65MSep 04View
Aug 02, 2019TIMOTHY MAYLEBENPRESIDENT & CEO5.00K$39.56$197.80KBUY7.56%71.16KAug 01View
Jul 25, 2019BB Biotech AG Martin GublerBB Biotech AG10% OWNER50.00K$42.65$2.13MBUY1.42%3.57MJul 23View
Jul 01, 2019TIMOTHY MAYLEBENPRESIDENT & CEO5.00K$46.00$230.00KBUY8.17%66.16KJun 28View
Apr 05, 2019Richard BartramCHIEF FINANCIAL OFFICER8.00K$42.88$343.05Ks258.73%11.09KApr 03View
Apr 01, 2019TIMOTHY MAYLEBENPRESIDENT & CEO5.00K$40.00$200.00KBUY8.90%61.16KMar 29View
Mar 21, 2019TIMOTHY MAYLEBENPRESIDENT & CEO5.00K$43.48$217.40KBUY9.77%56.16KMar 20View
Mar 21, 2019NICOLE VITULLODIRECTOR-1.12M$44.73-$685.60KSELL-99.26%8.32KMar 19 - Mar 21View
Mar 15, 2019TARGET BIOTECH VAG BIOTECH BB10% OWNER50.00K$49.89$2.49MBUY1.44%3.52MMar 14View
Mar 14, 2019TIMOTHY MAYLEBENPRESIDENT & CEO5.00K$48.73$243.65KBUY10.83%51.16KMar 14View
Mar 14, 2019ROGER NEWTONDIRECTOR-25.00K$50.06-$1.25MSELL-4.36%548.73KMar 12View
Jan 07, 2019TARGET BIOTECH VAG BIOTECH BB10% OWNER80.00K$41.29$3.30MBUY2.36%3.47MJan 04View
Dec 26, 2018TARGET BIOTECH VAG BIOTECH BB10% OWNER50.00K$39.91$2.00MBUY1.50%3.39MDec 24View
Dec 19, 2018TARGET BIOTECH VAG BIOTECH BB10% OWNER60.00K$47.73$2.86MBUY1.83%3.34MDec 17View
Nov 05, 2018Boxer Capital LLCBoxer Asset Management IncJOSEPH LEWIS10% OWNER-100.00K$56.38-$5.64MSELL-8.32%1.10MNov 02 - Nov 05View
Nov 02, 2018ROGER NEWTONDIRECTOR-2.83K$50.07-$141.55KSELL-0.49%573.73KNov 01 - Nov 02View
Oct 18, 2018ROGER NEWTONDIRECTOR-22.17K$50.02-$1.11MSELL-3.70%576.55KOct 16 - Oct 18View
Aug 29, 2018ROGER NEWTONDIRECTOR-17.70K$51.05-$903.61KSELL-2.87%598.73KAug 27View
Aug 22, 2018ROGER NEWTONDIRECTOR-7.30K$50.06-$365.44KSELL-1.17%616.43KAug 17View
Aug 06, 2018TARGET BIOTECH VAG BIOTECH BB10% OWNER50.00K$46.14$2.31MBUY1.55%3.28MAug 03View
Jul 13, 2018TARGET BIOTECH VAG BIOTECH BB10% OWNER50.00K$41.77$2.09MBUY1.57%3.23MJul 12View
Jul 03, 2018TARGET BIOTECH VAG BIOTECH BB10% OWNER50.00K$39.48$1.97MBUY1.60%3.18MJun 29View
Jun 25, 2018TARGET BIOTECH VAG BIOTECH BB10% OWNER60.00K$38.57$2.31MBUY1.95%3.13MJun 21View
Jun 11, 2018TARGET BIOTECH VAG BIOTECH BB10% OWNER60.00K$37.79$2.27MBUY1.99%3.07MJun 07View
Jun 07, 2018TARGET BIOTECH VAG BIOTECH BB10% OWNER60.00K$38.47$2.31MBUY2.03%3.01MJun 05View
May 22, 2018TARGET BIOTECH VAG BIOTECH BB10% OWNER130.00K$40.11$5.21MBUY4.61%2.95MMay 18 - May 21View
Mar 29, 2018ROGER NEWTONDIRECTOR6.91K$72.56$484.15Ks1.12%623.73KMar 29View
Jan 26, 2018NICOLE VITULLODIRECTOR-796.73K$39.40-$837.93KSELL-97.00%24.65KJan 24 - Jan 26View
Dec 08, 2017NICOLE VITULLODIRECTOR-365.21K$53.85-$502.21KSELL-93.85%23.94KDec 06 - Dec 08View
Mar 23, 2017Daniel JanneyDIRECTOR-350.00K$45.80-$16.03MSELL-20.38%1.37MMar 21View
Mar 23, 2017Dov GoldsteinDIRECTOR-800.00K$41.66-$33.33MSELL-48.87%837.13KMar 21 - Mar 22View
Mar 22, 2017GILBERT OMENNDIRECTOR1.00K$42.26$42.26KBUY10.00%11.00KMar 21View
Nov 03, 2016Narendra LalwaniCHIEF OPERATING OFFICER5.00K$9.93$49.65KBUY∞5.00KNov 01View
Jul 07, 2016MARK MCGOVERNDIRECTOR5.00K$10.00$50.00KBUY∞5.00KJul 05 - Jul 06View
May 05, 2016TIMOTHY MAYLEBENPRESIDENT & CEO7.00K$14.85$103.95KBUY20.22%41.61KMay 04View
Mar 02, 2016GILBERT OMENNDIRECTOR5.00K$15.28$76.40KBUY100.00%10.00KMar 01View
Jan 28, 2016TIMOTHY MAYLEBENPRESIDENT & CEO3.60K$15.88$57.17KBUY11.61%34.61KJan 27View
Jan 19, 2016TIMOTHY MAYLEBENPRESIDENT & CEO7.20K$14.08$101.38KBUY30.23%31.01KJan 15View
Apr 27, 2015Aisling Capital II LPAISLING CAPITAL PARTNERS LPAISLING CAPITAL PARTNERS LLCANDREW SCHIFFDennis PurcellSTEVE ELMS10% OWNER-217.47K$108.22-$23.53MSELL-10.58%1.84MApr 23 - Apr 24View
Apr 27, 2015Dov GoldsteinDIRECTOR-217.47K$108.22-$23.53MSELL-10.58%1.84MApr 23 - Apr 24View
Mar 23, 2015Patrick G EnrightDIRECTOR-500.00K$111.66-$55.83MSELL-96.46%18.36KMar 19View
Nov 19, 2014Longitude Capital Partners LLCLongitude Capital Associates LPLongitude Venture Partners LPJuliet Bakker Tammenoms10% OWNER-487.13K$32.78-$15.97MSELL-94.53%28.19KNov 17 - Nov 18View
Nov 19, 2014Patrick G EnrightDIRECTOR-487.13K$32.78-$15.97MSELL-94.53%28.19KNov 17 - Nov 18View
Oct 21, 2014Alta Partners VIII LPAlta Partners Management VIII LLCFARAH CHAMPSIGUY NOHRA10% OWNER500.00K$20.00$10.00MBUY24.36%2.55MOct 21View
Oct 21, 2014Daniel JanneyDIRECTOR500.00K$20.00$10.00MBUY24.36%2.55MOct 21View
Oct 21, 2014GILBERT OMENNDIRECTOR5.00K$20.00$100.00KBUY∞5.00KOct 21View
Oct 21, 2014PARTERS DOMAIN VIIJ. Blair, B. Dovey, J. Treu, N. Vitullo and B. HalakJ. Blair, B. Dovey, J. Treu, N. Vitullo and B. HalakJ. Blair, B. Dovey, J. Treu, N. Vitullo and B. HalakKathleen K SchoemakerJ. Blair, B. Dovey, J. Treu, N. Vitullo and B. HalakJ. Blair, B. Dovey, J. Treu, N. Vitullo and B. HalakDIRECTOR500.00K$20.00$10.00MBUY24.19%2.57MOct 21View
Oct 14, 2014Longitude Capital Partners LLCLongitude Capital Associates LPLongitude Venture Partners LPJuliet Bakker Tammenoms10% OWNER-943.00$30.00-$28.29KSELL-2.44%37.76KOct 09View
Oct 14, 2014Patrick G EnrightDIRECTOR-943.00$30.00-$28.29KSELL-2.44%37.76KOct 09View
Oct 09, 2014Patrick G EnrightDIRECTOR-11.93K$30.04-$358.29KSELL-24.00%37.78KOct 07View
Oct 09, 2014Longitude Capital Partners LLCLongitude Capital Associates LPLongitude Venture Partners LPJuliet Bakker Tammenoms10% OWNER-11.93K$30.04-$358.29KSELL-24.00%37.78KOct 07View
Jul 02, 2013JAMES BLAIR10% OWNER2.10M$14.00$4.00MBUY∞35.25KJul 01View
Jul 02, 2013DP VII ASSOCIATES LP10% OWNER35.25K$14.00$67.07KBUY∞35.25KJul 01View
Jul 02, 2013Kathleen K. Schoemaker Managing Member of One Palmer Square Associates VII, LLC, General Partner of Domain Partners VII, L.P.10% OWNER2.07M$14.00$3.93MBUY∞2.07MJul 01View
Jul 02, 2013Brian Halak10% OWNER2.10M$14.00$4.00MBUY∞35.25KJul 01View
Jul 02, 2013BRIAN DOVEY10% OWNER2.10M$14.00$4.00MBUY∞35.25KJul 01View
Jul 02, 2013Kathleen K Schoemaker10% OWNER2.10M$14.00$4.00MBUY∞35.25KJul 01View
Jul 02, 2013JESSE TREU10% OWNER2.10M$14.00$4.00MBUY∞35.25KJul 01View
Jul 02, 2013NICOLE VITULLODIRECTOR2.10M$14.00$4.00MBUY∞35.25KJul 01View
Jul 01, 2013Longitude Capital Partners LLCLongitude Capital Associates LPLongitude Venture Partners LPJuliet Bakker Tammenoms10% OWNER1.93M$14.00$3.03MBUY∞38.01KJul 01View
Jul 01, 2013TIMOTHY MAYLEBENPRESIDENT AND CEO5.00K$14.00$70.00KBUY21.00%28.81KJul 01View
Jul 01, 2013ROGER NEWTONEXECUTIVE CHAIRMAN, CSO343.40K$14.00$592.84KBUY119.95%629.68KJul 01View
Jul 01, 2013LOUIS LANGEDIRECTOR215.52K$14.00$199.00KBUY∞197.70KJul 01View
Jul 01, 2013MD DOV GOLDSTEINDIRECTOR2.05M$14.00$3.33MBUY∞2.05MJul 01View
Jul 01, 2013PATRICK ENRIGHTDIRECTOR1.93M$14.00$3.03MBUY∞38.01KJul 01View
Jul 01, 2013DANIEL JANNEYDIRECTOR2.05M$14.00$3.30MBUY∞2.05MJul 01View
Jul 01, 2013Alta Partners VIII LPAlta Partners Management VIII LLCFARAH CHAMPSIGUY NOHRA10% OWNER2.05M$14.00$3.30MBUY∞2.05MJul 01View
Jul 01, 2013Aisling Capital II LPAISLING CAPITAL PARTNERS LPAISLING CAPITAL PARTNERS LLCANDREW SCHIFFDennis PurcellSTEVE ELMS10% OWNER2.05M$14.00$3.33MBUY∞2.05MJul 01View

FAQ

Q

Est-ce que le trading d'initiés est légal ?

A
Le trading d'initiés est légal tant que les initiés signalent ces transactions à la SEC. Le trading de titres illégal se produit lorsque l'initié enfreint un devoir fiduciaire ou omet de signaler ses transactions.
Q

Quels sont quelques exemples de manipulation de marché ?

A
Le trading d'initiés, les schémas de gonflement et de vidage, le front running et les opérations de lavage sont tous des exemples de manipulation de marché. Les investisseurs qui suivent les mouvements d'actifs des initiés devraient réfléchir attentivement à la raison pour laquelle ces initiés échangent leurs actions avant de passer à l'action.

Actualités sur les transactions d'initiés de ESPR

Chief Medical Officer at Esperion Therapeutics Acquires Company Stock Options Worth 89,300 Shares

Benzinga Insights

Esperion Therapeutics And 2 Other Stocks Under $3 Insiders Are Aggressively Buying

The Dow Jones closed slightly lower on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Lisa Levin

Esperion Therapeutics General Counsel Awarded $336K Worth of Stock Options

Benzinga Insights

Chief Medical Officer at Esperion Therapeutics Acquires Company Stock Options Worth 122,500 Shares

Benzinga Insights

Chief Financial Officer at Esperion Therapeutics Acquires Company Stock Options Worth 39,000 Shares

Benzinga Insights

Les gens regardent aussi

Theravance Biopharma Inc
NASDAQ:TBPH
$19.53
%
Zevra Therapeutics Inc
NASDAQ:ZVRA
$8.38
-1.39%
GH Research PLC
NASDAQ:GHRS
$14.70
%
Bioage Labs Inc
NASDAQ:BIOA
$19.58
0.05%
Xeris Biopharma Holdings Inc
NASDAQ:XERS
$6.77
-0.73%
Neumora Therapeutics Inc
NASDAQ:NMRA
$3.23
0.94%
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
$12.01
-0.08%
Aquestive Therapeutics Inc
NASDAQ:AQST
$3.62
-0.82%

Parcourir transactions d'initiés sur toutes les actions.

Données et API: API Benzinga · API d'actualités boursières · API de notations d'analystes · API de logo d'entreprise

Données de marché fournies par API Benzinga

Benzinga

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL

© 2026 Benzinga | All Rights Reserved